Company: CRVO
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001437749-25-013543
Chunk: 63

Company: CervoMed Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 63
---
 common stock were available for future grants under the 2015 Equity Plan. |

| ● | 909,419 shares of our common stock were issuable upon the exercise of outstanding stock options (vested and unvested) with a weighted average exercise price of $13.23 per share. These stock options consist of non-plan options granted outside any formal plan, as well awards granted under our 2015 Equity Plan and 2018 Equity Plan. |

| ● | No shares underlying full value awards (such as restricted stock, RSUs and performance share awards) were outstanding. |

If the 2025 Plan is approved by our stockholders, we intend to grant any future stock options and other equity awards under the 2025 Plan.

Historical and Anticipated Equity Award Granting Practices. In setting the number of shares authorized for issuance under the 2025 Plan, we considered the historical number of equity awards granted in the past two full fiscal years and our anticipated equity award granting practices. The following table sets forth information regarding equity awards granted and the annual burn rate for each of the last two fiscal years. The amounts in the following table are not necessarily indicative of awards that might be awarded under the 2025 Plan.

|                                                       |     | 2024 |           |   |    |     | 2023 |           |   |
| Stock options granted                                 |     |      |   310,996 |   | -1 |     |      |   198,600 |   |
| Full-value awards or shares granted or earned         |     |      |         0 |   |    |     |      |         0 |   |
| Basic common shares outstanding as of fiscal year end |     |      | 8,702,719 |   |    |     |      | 5,674,520 |   |
| Burn rate                                             |     |      |      3.57 | % |    |     |      |      3.50 | % |

| (1) | Includes 32,000 shares granted to a non-executive employee on October 15, 2024, the continued holding of which was contingent upon the annual automatic increase in the share pool under the 2015 Equity Plan occurring and being sufficient to cover all shares of Common Stock underlying such award (and if such automatic increase was not so sufficient, the award would terminate immediately on January 2, 2025 with no compensation or other payment due). |

We also considered our